Preclinical meritorious anticancer effects of Metformin against breast cancer: An <i>In vivo</i> trial.

Rizvi, Fatima; Shaukat, Lubna; Azhar, Arfa; Jafri, Alia; Aslam, Unum; Imran-Ul-Haq, Hafiz

Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial.

Rizvi, Fatima; Shaukat, Lubna; Azhar, Arfa; Jafri, Alia; Aslam, Unum; Imran-Ul-Haq, Hafiz.

Afiliação

Rizvi F; Dow International Medical College (DUHS), Department of Pharmacology, Karachi, Pakistan.
Shaukat L; DUHS, Department of Oral and Maxillofacial Surgery, Karachi, Pakistan.
Azhar A; AKUH, Department of Biological and Biomedical Sciences, Karachi, Pakistan.
Jafri A; Department of Biochemistry Institute, JSMU, Karachi, Pakistan.
Aslam U; Lahore, Pakistan.
Imran-Ul-Haq H; Department of Pharmacology, DUHS, Karachi, Pakistan.

J Taibah Univ Med Sci ; 16(4): 504-512, 2021 Aug.

Article em En | MEDLINE | ID: mdl-34408607

Palavras-chave

Athymic; CDX model; MCF-7; Metformin; Tumour Volume

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Taibah Univ Med Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Paquistão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google